#Spain #Madrid #Corify Care #cardiac arrhythmias #ACORYS Mapping

Transforming Cardiac Care: Corify Care's Innovative Mapping Technology

Corify Care has made waves in the medical field with its pioneering technology aimed at enhancing cardiac care for patients suffering from complex arrhythmias. Recently, the company announced the publication of two key studies in prestigious journals, Heart Rhythm and Europace, affirming the effectiveness of its 4-D global cardiac mapping system. This validation marks a turning point in the way that healthcare providers diagnose and treat conditions such as atrial fibrillation (AF) and ventricular tachycardia (VT).

The Need for Speed in Atrial and Ventricular Mapping

Conventional arrhythmia mapping techniques often involve lengthy procedures that can put patients at risk. Typically, these methods require inducing unstable heart rhythms or depend on pre-procedural imaging—both of which can result in significant delays and discomfort for patients.

Corify Care’s ACORYS® mapping system changes this paradigm by offering instant clarity about the heart's electrical activity. This shift allows physicians to gather crucial data even before beginning the ablation process, thus streamlining operations in the electrophysiology (EP) lab.

Clinical Insights from Recent Studies

The studies published in Heart Rhythm and Europace highlight how the ACORYS® system can swiftly identify the arrhythmogenic substrate responsible for ventricular tachycardia while the heart is in a stable sinus rhythm. This real-time insight eliminates the need for inducing potentially harmful arrhythmias, allowing for a safer experience for the patient.

Jana Reventós, MSc, Clinical Affairs Manager and lead author of the Europace paper, emphasizes the advantages provided by this technology, stating, "We are eliminating guesswork in complex ablation. For the first time, clinicians can see arrhythmia circuits instantly—without imaging dependencies or procedural risk—enabling confident, targeted intervention from the outset."

The Heart Rhythm study, known as NIAVAS, supports these claims by showcasing how the innovative mapping approach enhances procedural efficiency and reduces risks associated with traditional methods.

A Comprehensive Approach to Patient Care

The data collected through Corify's mapping technology isn’t just significant for procedural efficiency; it directly benefits patient outcomes. As Dr. Ivo Roca-Luque, Head of the Arrhythmia Section at Hospital Clínic de Barcelona, notes,

"With Corify's technology, we see the full arrhythmia substrate instantly and continuously. This leads to more targeted ablation, shorter procedures, and less risk for the patient."

Regulatory Approval and Future Prospects

Corify Care's ACORYS Mapping System has successfully complied with European regulations and has also received FDA 510(k) clearance in the U.S. This dual compliance not only solidifies its reliability but also signifies its potential for widespread adoption in clinical practices across multiple regions.

As the company prepares to present additional clinical data at the Heart Rhythm Society (HRS) 2026 meeting scheduled for April 23–26 in Chicago, attention is focused on how this technology could further evolve the field of electrophysiology.

Conclusion

In summary, Corify Care's innovative cardiac mapping technology represents a leap forward in the management and treatment of complex arrhythmias. By enabling instant visualization of cardiac activity, the ACORYS® system empowers physicians to achieve optimal ablation strategies, thereby enhancing patient safety and procedural outcomes. This is not merely a technological advancement but a complete rethinking of how cardiac care can be approached, offering hope for more effective and considerate patient management in the future.